Angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists

Archives of Otolaryngology - Head and Neck Surgery

Volumn 130, Issue 12, 2004, Pages 1416-1419

  Kyrmizakis, Dionysios E ^a   Papadakis, Chariton E ^a   Liolios, Antonios D ^c   Karatzanis, Alexandros D ^a   Malandrakis, Stylianos ^a   Skoulakis, Charalambos E ^b   Bizakis, John G ^a   Velegrakis, George A ^a  

^a UNIVERSITY HOSPITAL OF IRAKLION   (Greece)

^b General Hospital   (Greece)

^c CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTIHISTAMINIC AGENT; CANDESARTAN HEXETIL; CAPTOPRIL; CAPTOPRIL PLUS HYDROCHLOROTHIAZIDE; COMPLEMENT COMPONENT C1S INHIBITOR; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL MALEATE; ENALAPRIL PLUS HYDROCHLOROTHIAZIDE; HYDROCHLOROTHIAZIDE PLUS LISINOPRIL; LISINOPRIL; LOSARTAN POTASSIUM; QUINAPRIL; RAMIPRIL; VALSARTAN;

ADULT; AGED; ANGIONEUROTIC EDEMA; ARTICLE; CHRONIC DRUG ADMINISTRATION; CLINICAL ARTICLE; DYSPHAGIA; DYSPNEA; EDEMA; FEMALE; HEART ARRHYTHMIA; HUMAN; LARYNX EDEMA; LIP; MALE; MOUTH; MUCOSA EDEMA; PALATE; SOFT PALATE; TACHYCARDIA; TONGUE;

ANGIONEUROTIC EDEMA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; FEMALE; HUMANS; LARYNGEAL EDEMA; MALE; MIDDLE AGED; MOUTH DISEASES; PALATE, SOFT; RECEPTORS, ANGIOTENSIN; RETROSPECTIVE STUDIES; TONGUE DISEASES; UVULA;

EID: 10044258520     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.130.12.1416     Document Type: Article

References (12)

1. Agah R, Bandi V, Guntupalli KK. Angioedema: the role of ACE inhibitors and factors associated with poor clinical outcome. Intensive Care Med. 1997; 23:793-796.
2. Kyrmizakis DE, Papadakis CE, Fountoulakis EJ, Liolios AD, Skoulas JG. Tongue angioedema after long-term use of ACE inhibitors. Am J Otolaryngol. 1998;19:394-396.
3. Donaldson VH, Evans RR. A biochemical abnormality in hereditary angioneurotic edema: absence of serum inhibitor C1 esterase. Am J Med. 1963;35:37-44.
4. Pracy JP, McGashan JA, Walsh RM, Gleeson MJ. Angioedema secondary to angiotensin-converting inhibitors. J Laryngol Otol. 1994; 108:696-698.
5. Carr AA, Prisant LM. Losartan: first of a new class of angiotensin antagonists for the management of hypertension. J Clin Pharmacol. 1996;36:3-12.
6. Chiu AG, Krwiak EJ, Deeb ZE. Angioedema associated with angiotensin II receptor antagonists: challenging our knowledge of angioedema and its etiology. Laryngoscope. 2001;111:1729-1731.
7. Israili ZH, Hall WD. Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy: a review of the literature and pathophysiology. Ann Intern Med. 1992; 117:234-242.
8. Abdi R, Dong VM, Lee CJ, Ntoso KA. Angiotensin II receptor blocker-associated angioedema: on the heels of ACE inhibitor angioedema. Pharmacotherapy. 2002;22:1173-1175.
9. Lo KS. Angioedema associated with candesartan. Pharmacotherapy. 2002;22:1176-1179.
10. Sharma PK, Yium JJ. Angioedema associated with angiotensin II receptor antagonist losartan. South Med J. 1997;90:552-553.
11. Slater EE, Merrill DD, Guess HA, et al. Clinical profile of angioedema associated with angiotensin converting enzyme inhibition. JAMA. 1988;260: 967-970.
12. Tisch M, Lampl L, Groh A, Maier H. Angioneurotic edemas of the upper aerodigestive tract after ACE-inhibitor treatment. Eur Arch Otorhinolaryngol. 2002; 259:419-421.